Steven Artandi
Academic Appointments
- Associate Professor, Medicine - Hematology
- Member, Bio-X
- Member, Cancer Center
Contact Information
-
Clinical Offices
Hematology Clinic 300 Pasteur Dr A175 MC 5312 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 725-8950Hematology Clinic 875 Blake Wilbur Dr Clinic C Stanford, CA 94305-5820 Tel Work (650) 498-6000 Fax (650) 498-5030
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cancer> Hematology
- Medical Oncology
Honors and Awards
- Fellow, American Association for the Advancement of Science (AAAS) (2008)
Professional Education
| Residency: | Massachusetts General Hospital, MA (1997) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2001) |
| Fellowship: | Dana-Farber Cancer Institute, MA (2000) |
| Medical Education: | Columbia University, NY (1995) |
| Ph.D.: | Columbia University, Microbiology (1995) |
Postdoctoral Advisees
Jinkuk Choi , Jae-Il Park , Marina Shkreli , Luis Francisco Zirnberger Batista
Graduate & Fellowship Program Affiliations
Web Site Links
Scientific Focus
Current Research Interests
Telomeres, the nucleotide repeats that cap the ends of eukaryotic chromosomes, serve critical roles in promoting cell viability and in maintaining chromosomal stability. In humans, telomeres shorten progressively with cell division and aging because DNA polymerase cannot fully replicate the extreme ends of chromosomes. Critical telomere shortening and loss of the protective telomere capping function in cell culture initiates senescence and crisis responses that profoundly alter chromosome stability, cell cycle progression and survival. Expression of telomerase, the reverse transcriptase that synthesizes telomere repeats, is sufficient to lengthen and stabilize telomeres, thus enabling cells to proliferate in an unlimited fashion. Telomerase is expressed in stem cells and progenitor cells in self-renewing tissues, is downregulated with differentiation and upregulated in the vast majority of human cancers. In the Artandi lab, we are interested in unraveling the molecular and cellular mechanisms according to which telomeres and telomerase modulate stem cell function and carcinogenesis.
TERT and STEM CELLS
Telomerase is comprised of two subunits: TERT, the telomerase reverse transcriptase, and TERC, the telomerase RNA component. In stem cell and progenitor cell compartments, TERT serves a critical role in maintaining telomere length and function to support tissue homeostasis. However, TERT serves an additional function in stem cells, distinct from its role in telomere lengthening. Using a conditional transgenic mouse system, we recently showed that TERT can promote proliferation of quiescent epidermal stem cells. Induction of TERT in mouse skin caused a rapid transition in hair follicle from the resting phase (telogen) to the active phase (anagen) of the hair follicle cycle and robust hair growth. We showed that this novel function for TERT was independent of TERC and therefore independent of TERT's previously understood role in telomere synthesis....
Clinical Trials
Publications
- Telomeres and telomerase in cancer. Carcinogenesis. 2010; (1): 9-18
- A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science. 2009; (5914): 644-8
- Telomerase modulates Wnt signalling by association with target gene chromatin. Nature. 2009; (7251): 66-72
- Reverse transcribing the code for chromosome stability. Mol Cell. 2009; (5): 715-9
- TCAB1: driving telomerase to Cajal bodies. Cell Cycle. 2009; (9): 1329-31

